Syneos Health buys second company in a month to scale up data science capabilities

OCT 06, 2021

Image: Syneos Health website

MORRISVILLE – Syneos Health (Nasdaq:SYNH) has bought RxDataScience in another deal to expand its service offerings.

It’s the second acquisition that Syneos has made in the prior four weeks. In mid-September it acquired StudyKik.

“This acquisition boosts our ability to deliver strategic insights and technology-enabled solutions that address our customers’ most complex data challenges,” said Alistair Macdonald, CEO of Syneos Health in a statement announcing the RxDataScience deal.

RxDataScience built a scalable platform for biopharmaceutical companies to ” transform vast volumes of data into strategic, actionable insights,” the statement reads. Syneos said in its statement that following the acquisition, the company “will offer biopharma customers technology-enabled, insights-powered solutions with the aim of accelerating performance across the product lifecycle – from lab to life.”

The company stated the acquisition would enable the company to scale its data science capabilities.

“Combining our end-to-end services and deep behavioral and therapeutic expertise with their AI and data-science capabilities will generate customer strategies to accelerate product development and time to market,” said Macdonald.

RxDataScience is now a part of the Syneos Health Dynamic Assembly® network, the company stated.

Similar articles you can read